TO THE EDITOR: We read with interest the article by Ohira et al.(1). The authors investigated
inter-and intraobserver agreement in 18F-FDG PET/CT interpretation for patients with …

Recent studies have reported the usefulness of 18F-FDG PET in aiding with the diagnosis
and management of patients with cardiac sarcoidosis (CS). However, image interpretation of …

Optimizing our imaging capabilities for patients with cardiac sarcoidosis is critical as it has
diagnostic, prognostic, and therapeutic implications. 18 FDG PET/CT has the highest …

We thank Dr. Lu and Dr. Sweiss for their comments on the “Joint SNMMI–ASNC Expert
Consensus Document on the Role of 18 F-FDG PET/CT in Cardiac Sarcoid Detection and …

Cardiac sarcoidosis is a potentially fatal complication of sarcoidosis. The 1993 guidelines of
the Ministry of Health, Labour, and Welfare (MHLW) of Japan have been used as the …

Sarcoidosis is an idiopathic systemic granulomatous disease that can affect multiple organs.
The adjusted annual incidence among black Americans is roughly three times that among …

We thank Drs. Njeim, Bogun, and Crawford for their interest in our study (1). We agree that in
the absence of histological confirmation of sarcoidosis, it is possible that there may be other …

Aims To evaluate the value of 18F-fluoro-2-deoxyglucose positron emission tomography
(18F-FDG PET) in detecting cardiac sarcoidosis. Methods and results Thirty-two patients …

Though diagnosing cardiac sarcoidosis remains a challenge, knowledge of the clinical entity
has increased over time. The differential diagnosis for a patient with new conduction …

Purpose Despite accumulating reports on the clinical value of 18 F-fluoro-2-deoxyglucose
positron emission tomography (18 F-FDG PET) and magnetic resonance imaging (MRI) in …